We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Circulating Tumor Cells (CTCs): Tracking the Spread of Cancer

Video   Jul 27, 2018 | Original video from the Lawson Health Research Institute

 

Recently, a study was published in JAMA Oncology which was one of the first to demonstrate that a blood test can predict how patients with advanced prostate cancer will respond to specific treatments, leading to improved survival.

Dr. Allan is a national leader in the study of circulating tumor cells, which were identified in the study. Her lab, at the Lawson Health Research Institute, has developed unique blood tests to track metastasis by measuring the number of CTCs in a patient’s blood stream.

Watch to find out how the CELLSEARCH® Circulating Tumor Cell (CTC) Test and the London Regional Cancer Program (Canada) helps to inform clinical decisions in patients with metastatic breast, prostate and colorectal cancer.




 
More Information
 
 
 

Recommended Videos

Ready for a change of scenery?

Video

Get a new perspective on your sample QC with the Agilent 4150 TapeStation system and open up new horizons. Ideal for handling smaller numbers of samples, the system with ScreenTape assays delivers fast, reliable results within any NGS workflow.

WATCH NOW

Cell Culture Basics

Video

An overview of aseptic techniques

WATCH NOW

Allergic Reaction Signature Detected in 5 Minutes

Video

abbieSense is a Wyss technology that can detect histamine levels in human body fluids and determine the severity of an allergic reaction, which could help save the lives of patients with severe allergies.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE